Literature DB >> 16956437

Hematologic manifestations of primary Sjögren's syndrome.

P Manganelli1, P Fietta, F Quaini.   

Abstract

Sjögren's syndrome (SS) is a chronic autoimmune disorder, primarily characterized by the mononuclear cell infiltration of exocrine glands exiting in parenchymal damage and secretory impairment. The spectrum of the disease extends from an autoimmune exocrinopathy to a systemic process with extraglandular manifestations. SS is defined as primary (pSS) when isolated, or secondary when associated with another autoimmune disease. Patients with pSS may present hematologic abnormalities, such as anemia, hemocytopenias, monoclonal gammopathies and lymphoprolipherative disorders, predominantly non-Hodgkin's lymphoma of B-cell origin. The increased prevalence of B-cell malignancies suggests that SS may be a boundary disease between autoimmunity and lymphoproliferation. In this paper, the hematologic manifestations of pSS are reviewed.

Entities:  

Mesh:

Year:  2006        PMID: 16956437

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  6 in total

Review 1.  What can Sjögren's syndrome-like disease in mice contribute to human Sjögren's syndrome?

Authors:  Ammon B Peck; Cuong Q Nguyen
Journal:  Clin Immunol       Date:  2017-05-03       Impact factor: 3.969

2.  Clinical interest of bone marrow aspiration in rheumatology: a practice-based observational study of 257 bone marrow aspirations.

Authors:  Amélie Loctin; François Bailly; Davy Laroche; Christian Tavernier; Jean-Francis Maillefert; Paul Ornetti
Journal:  Clin Rheumatol       Date:  2012-10-02       Impact factor: 2.980

Review 3.  Management of relapsed/refractory marginal zone lymphoma: focus on ibrutinib.

Authors:  Nathan M Denlinger; Narendranath Epperla; Basem M William
Journal:  Cancer Manag Res       Date:  2018-03-27       Impact factor: 3.989

4.  Combined therapy with rituximab plus cyclophosphamide/vincristine/prednisone for Sjogren's syndrome-associated B-cell non-Hodgkin's lymphoma.

Authors:  J Carbone; R Perez-Fernandez; A Muñoz; P Sabin; L Carreño; E Fernandez-Cruz
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 10.817

5.  Elevated Plasma P-Selectin Autoantibodies in Primary Sjögren Syndrome Patients with Thrombocytopenia.

Authors:  Ya-Hui Hu; Peng-Fei Zhou; Guang-Feng Long; Xin Tian; Yu-Fan Guo; Ai-Ming Pang; Ran Di; Yan-Na Shen; Yun-De Liu; Yu-Jie Cui
Journal:  Med Sci Monit       Date:  2015-11-28

Review 6.  Sjögren's syndrome: a systemic autoimmune disease.

Authors:  Simone Negrini; Giacomo Emmi; Monica Greco; Matteo Borro; Federica Sardanelli; Giuseppe Murdaca; Francesco Indiveri; Francesco Puppo
Journal:  Clin Exp Med       Date:  2021-06-07       Impact factor: 3.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.